![]() | |||
|
Global Health Genetics Proteomics Outreach New Books Medical Education Collagen Remodeling Glimpsed Within Tumors Simple Surgical Checklist Cuts Deaths by 40 Percent Quest Finds Tool to Measure Energy Levels in Brain Cells Proceedings of the HMS Faculty Council Linde Professorship Offers Vision for Cancer Therapeutics Immune Disease Institute and Children’s Reach Affiliation Agreement Applications Requested for Rabkin Fellowships in Medical Education New Professorship Appointments HMS Red Book: Funding Opportunities for Junior Faculty and Postdocs |
MEDICAL EDUCATION
|
||
![]() Photo by Jan Reiss |
Research is a perpetual chain of questions, Sarah Henrickson discovered while she was completing her PhD. “I thought it was one question, and we'll answer it and be done,” she said. “It's a process. You just pick up the torch for awhile.” |
The day began with a panel of five faculty members who spoke about how
they combined successful academic and research careers with industry interactions.
Four students, including Stark and Henrickson, gave 15-minute presentations.
The day wrapped up with a poster session in the TMEC atrium.
Introducing the panel, HMS dean Jeffrey Flier announced he was convening and chairing a committee to review the HMS faculty conflict of interest policy. The committee will include senior and junior faculty and students, he said (see Focus, Jan. 23).
The HMS conflict-of-interest rules have worked well to protect academic integrity while furthering the mission of enhancing health and human welfare, the panelists said.
George Church, HMS genetics professor, said his open involvement with a dozen technology companies has helped break a virtual monopoly on DNA sequencing and bring down the costs almost 10,000-fold so far.

Photo by Jan Reiss
More than 100 Harvard medical students presented their research in the poster session at the longstanding and venerated forum for celebrating student research.
Elliott Antman, HMS professor of medicine at Brigham and Women’s Hospital,
credited clinical trials “conducted on a high moral plain” with
major improvements in the standard of coronary care. A collaboration between
Merck and the lab of Laurie Glimcher, the Irene Heinz Given professor of
immunology at HSPH and an HMS professor of medicine at BWH, has clear demarcation. “Our
job is to discover new genes in bone formation and resorption,” she
said. “Merck’s job is small-molecule screens to target those
pathways.” Glimcher also serves as a corporate director for Bristol
Myers Squibb Pharmaceutical Company.
Jerry Avorn, HMS professor of medicine at BWH, said the tensions and potential conflicts of interest are more likely to occur in clinical trials. “Sometimes we need to pay more attention than we do to the pitfalls on safety and cost, where there is the greater potential for non–win–win.”
“There is a really strong commitment to research at HMS,” said Terry Maratos-Flier, HMS associate professor of medicine at Beth Israel Deaconess Medical Center. She chaired the student research committee that planned the day. Research experience makes doctors who are better able to understand growing and changing scientific knowledge, and doctors do research that matters for patients.